Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Etoposide: an update.

R A Fleming1, A A Miller, C F Stewart

  • 1Department of Clinical Pharmacy, College of Pharmacy, Memphis, TN.

Clinical Pharmacy
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Etoposide, a chemotherapy drug, works by damaging cancer cell DNA. It shows significant efficacy in treating various cancers like lung and testicular cancer, despite potential side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The complex circumstellar environment of supernova 2023ixf.

Nature·2024
Same author

The effect of krill oil supplementation on skeletal muscle function and size in older adults: A randomised controlled trial.

Clinical nutrition (Edinburgh, Scotland)·2022
Same author

Cyst of round ligament of liver as a cause of pain syndrome in the right hypochondrium.

Vestnik khirurgii imeni I. I. Grekova·2018
Same author

A prospective study of weekly intensity modulated radiation therapy plan adaptation for head and neck cancer: improved target coverage and organ at risk sparing.

Australasian physical & engineering sciences in medicine·2018
Same author

ULTRASTRUCTURAL DIFFERENCES OF PRESPORES DEVELOPMENTAL STAGES AND MEIOSPORES OF SPECIES OF CLOSELY RELATED MICROSPORIDIA OF GENERA AMBLYOSPORA AND TRICHOCTOSPOREA (AMBLYOSPORIDAE: MICROSPORIDIA) FROM BLOOD-SUKING MOSQUITOES OF THE GENUS AEDES (DIPTERA: CULICIDAE).

Tsitologiia·2018
Same author

Ultrastructural Characteristics of the Testicular Interstitial Endocrinocytes of Adult Rats Subjected to Total Sialoadenectomy.

Bulletin of experimental biology and medicine·2018
Same journal

Criteria for use of epoetin alfa in adult cancer and orthopedic-surgery patients.

Clinical pharmacy·1993
Same journal

Accuracy of unbound-quinidine concentration determination after ultrafiltration.

Clinical pharmacy·1993
Same journal

Modified Michaelis-Menten equation for estimating unbound-phenytoin concentrations.

Clinical pharmacy·1993
Same journal

Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics.

Clinical pharmacy·1993
Same journal

Efficacy of nutritional supplements used by athletes.

Clinical pharmacy·1993
Same journal

Low-molecular-weight heparins for the treatment of deep-vein thrombosis.

Clinical pharmacy·1993
See all related articles

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Etoposide is a semi-synthetic derivative of podophyllotoxin.
  • Its cytotoxicity mechanism differs from its parent compound.
  • Etoposide's interaction with topoisomerase II is crucial for its anti-cancer effects.

Purpose of the Study:

  • To review the chemistry, pharmacology, pharmacokinetics, clinical efficacy, pharmacodynamics, and adverse effects of etoposide.
  • To discuss etoposide's disposition in patients with renal and hepatic dysfunction.
  • To evaluate etoposide's impact on survival in specific cancers.

Main Methods:

  • Review of existing literature on etoposide.
  • Analysis of pharmacokinetic data, including bioavailability and protein binding.

Related Experiment Videos

  • Compilation of clinical efficacy data from combination therapies.
  • Summary of reported adverse effects.

    • Main Results:

    • Etoposide stabilizes topoisomerase II-DNA complexes, inhibiting DNA repair.
    • Oral etoposide exhibits variable bioavailability (average 50%).
    • High protein binding (>95%) and significant urinary excretion (parent drug or glucuronide) observed.
    • High response rates (90% for small-cell lung cancer, 80% for testicular cancer) in combination therapies.
    • Common adverse effects include myelosuppression, alopecia, and gastrointestinal issues.

    Conclusions:

    • Etoposide demonstrates broad-spectrum anti-cancer activity.
    • It is effective in combination regimens for lung, testicular, and other cancers.
    • Understanding its pharmacokinetics and adverse effects is vital for optimal clinical use.